Epidemiology of diabetic retinopathy

Hospital Medicine

Volumn 64, Issue 7, 2003, Pages 396-399

  Chew, Emily Y ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE; CONFERENCE PAPER; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DYSLIPIDEMIA; HUMAN; HYPERGLYCEMIA; MEDICAL EXAMINATION; MEDICAL RESEARCH; RISK FACTOR; ANEMIA; HYPERLIPIDEMIA; HYPERTENSION; METABOLISM; REVIEW;

FIBRINOGEN; SERUM ALBUMIN;

ANEMIA; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FIBRINOGEN; HUMANS; HYPERGLYCEMIA; HYPERLIPIDEMIAS; HYPERTENSION; RISK FACTORS; SERUM ALBUMIN;

EID: 0042887436     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: 10.12968/hosp.2003.64.7.2275     Document Type: Conference Paper

References (34)

1. Arfken CL, Salicrup AE, Meuer SM et al (1994) Retinopathy in African Americans and whites with insulin-dependent diabetes mellitus. Arch Intern Med 154: 2597-602
2. Chaturvedi N, Sjolie AK, Stephen JM et al and the EUCLID Study Group (1998) Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. Lancet 351: 28-31
3. Chew EY, Klein ML, Ferris FL III et al for the ETDRS Research Group (1996) Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Arch Ophthalmol 114: 1079-84
4. Davis MD, Fisher MR, Gangnon RE et al (1998) Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Invest Ophthalmol Vis Sci 39: 233-52
5. Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-86
6. Diabetes Control and Complications Trial Research Group (1995a) The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. Arch Ophthalmol 113: 36-51
7. Diabetes Control and Complications Trial Research Group (1995b) The relationship of glycemic exposures (HbA1C) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 44: 968
8. Diabetes Control and Complications Trial Research Group (1996) Perspectives in Diabetes: the absence of a glycemic threshold for the development of long-term complications. The perspective of the Diabetes Control and Complications Trial. Diabetes 45: 1289-98
9. Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications Research Group (2000) Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 342: 381-9
10. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287: 2563-9
11. Fong DS, Segal PP, Myers F, Ferris FL, Hubbard LD, Davis MD (1997) Subretinal fibrosis in diabetic macular edema: ETDRS report no. 23. Arch Ophthalmol 115: 873-7
12. Janka HU, Warram JH, Rand LI, Krolewski AS (1989) Risk factors for progression of background retinopathy in long-standing IDDM. Diabetes 38: 460-4
13. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL (1984a) The Wisconsin Epidemiologic Study of Diabetic Retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102: 520-6
14. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL (1984b) The Wisconsin Epidemiologic Study of Diabetic Retinopathy: III. prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102: 527-32
15. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL (1988) Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 260: 2864-71
16. Klein R, Moss SE, Klein BEK, Davis MD, DeMets DL (1989) The Wisconsin Epidemiology Study of Diabaetic Retinopathy Report. XI. The incidence of macular edema. Ophthalmology 96: 1501-10
17. Klein BEK, Moss SE, Klein R, Surawicz TS (1991) The Wisconsin Epidemiologic Study of Diabetic Retinopathy: X. relationship of serum cholesterol to retino-pathy and hard exudate. Ophthalmology 98: 1261-5
18. Klein R, Klein BEK, Moss SE, Cruickshanks KJ (1994) Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med 154: 2169-78
19. Klein R, Klein B, Moss S (1996) Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med 124: 90-6
20. Kostraba JN, Klein R, Dorman JS et al (1991) The epidemiology of diabetes complications study: IV. correlates of diabetic back-ground and proliferative retinopathy. Am J Epidemiol 133: 381-91
21. Krolewski AS, Warram JH, Rand LI, Christlieb AR, Busick EJ, Kahn CR (1986) Risk of proliferative diabetic retinopathy in juvenile-onset type I diabetes: a 40-yr follow-up study. Diabetes Care 9: 443-52
22. Krolewski AS, Barzilay J, Warram JH, Martin BC, Pfeifer M, Rand LI (1992) Risk of early-onset proliferative diabetic retinopathy in IDDM is closely related to cardiovascular autonomic neuropathy. Diabetes 41: 430-7
23. Lloyd CE, Klein R, Maser RE, Kuller LH, Becker DJ, Orchard TJ (1995) The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study. J Diabetes Complications 3: 140-8
24. Marshall G, Garg SK, Jackson WE, Holmes DL, Chase HP (1993) Factors influencing the onset and progression of diabetic retinopathy in subjects with insulin-dependent diabetes mellitus. Ophthalmology 100: 1133-9
25. McMillan DE, Malone JI, Rand LJ, Steffes M (1986) Hemorheological plasma proteins predicts future retinopathy and nephropathy in the DCCT. Diabetologia 29: 23-9
26. McMillan DE, Malone JI, Rand LJ (1995) Progression of diabetic retinopathy is linked to rheologic plasma proteins in the DCCT. Diabetes 44: 54A
27. Ohkubo Y, Hideke K, Eiichi A et al (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28: 103-17
28. Qiao Q, Keinänen-Kiukaanniemi S, Läärä E (1997) The relationship between hemoglobin levels and diabetic retinopathy. J Clin Epidemiol. 50: 153-8
29. Reichard P, Nilsson BY, Rosenqvist U (1993) The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329: 304-9
30. Tesfaye S, Stevens LK, Stephenson JM et al (1995) Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 102: 647-61
31. Teuscher A, Schnell H, Wilson PWF (1988) Incidence of diabetic retinopathy and relationship to baseline plasma glucose and blood pressure. Diabetes Care 11: 246-51
32. UK Prospective Diabetes Study Group (1998a) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-53
33. UK Prospective Diabetes Study Group (1998b) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352: 854-65
34. UK Prospective Diabetes Study Group (1998c) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J 317: 703-13